# Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis

> **NCT00332904** · PHASE4 · UNKNOWN · sponsor: **Hvidovre University Hospital** · enrollment: 22 (actual)

## Conditions studied

- Liver Cirrhosis
- Portal Hypertension

## Interventions

- **DRUG:** propranolol
- **DRUG:** spironolactone

## Key facts

- **NCT ID:** NCT00332904
- **Lead sponsor:** Hvidovre University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-08
- **Primary completion:** 2008-07
- **Final completion:** 2010-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2010-06-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00332904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00332904, "Effect of Betablocker or Aldosterone Antagonist Therapy on Patients With Liver Cirrhosis". Retrieved via AI Analytics 2026-07-31 from https://api.ai-analytics.org/clinical/NCT00332904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*